StockDriftsStockDriftsTop 29 Rosalind Advisors INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | 15.61% | 3.30M | $41.6M | +0.00%(+0) | $7.06(+140.89%) | 2026-06-30 | |
| FENC | FENNEC PHARMACEUTICALS INC | 12.87% | 3.19M | $34.3M | +9.62%(+279.80K) | $6.75(+78.61%) | 2026-06-30 | |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 8.65% | 2.91M | $23.0M | -9.99%(-322.72K) | $4.32(+92.68%) | 2026-06-30 | |
| SVRA | SAVARA INC | 7.35% | 3.18M | $19.6M | -0.80%(-25.60K) | $3.41(+58.38%) | 2026-06-30 | |
| VSTM | VERASTEM INC | 5.72% | 3.99M | $15.2M | +86.42%(+1.85M) | $4.86(+37.20%) | 2026-06-30 | |
| XFOR | X4 PHARMACEUTICALS INC | 5.64% | 3.21M | $15.0M | +0.00%(+0) | $3.27(+31.08%) | 2026-06-30 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 5.31% | 988.2K | $14.1M | -4.68%(-48.51K) | $13.25(+2.63%) | 2026-06-30 | |
| HELP | CYBIN INC | 4.86% | 1.96M | $12.9M | +27.74%(+425.00K) | $8.67(+32.02%) | 2026-06-30 | |
| VOR | VOR BIOPHARMA INC | 4.49% | 648.6K | $11.9M | -7.34%(-51.40K) | $15.47(+50.56%) | 2026-06-30 | |
| PCVX | VAXCYTE INC | 4.37% | 200.0K | $11.6M | -31.03%(-90.00K) | $52.13(+14.86%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (10 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +26.59% |
| Top 20 Holdings Unweighted | — | — | — | — | +17.32% |
Rosalind Advisors INC reports $269.20M in US-listed equity holdings across 29 positions in its most recent 13F filing. Its largest disclosed positions are DCTH (15.6%), FENC (12.9%) and XERS (8.7%). The top 20 holdings account for 95.16% of reported assets. Its disclosed equity book has returned +26.59% cumulatively over 10 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Rosalind Advisors INC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Rosalind Advisors INC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1622627). View Rosalind Advisors INC’s 13F filings on SEC